Wnt/β-catenin-activated Ewing sarcoma cells promote the angiogenic switch

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Wnt/β-catenin signaling is active in a subset of Ewing sarcoma cells, correlating with a metastatic phenotype.
• These activated cells influence the tumor microenvironment (TME) by altering extracellular matrix (ECM) protein secretion.

Purpose of the Study:

• To investigate how Wnt/β-catenin-active Ewing sarcoma cells contribute to disease progression via TME modulation.
• To identify specific mechanisms by which these cells promote tumor growth and metastasis.

Main Methods:

• Analysis of transcriptomic data from patient biopsies and isolated tumor cells.
• In silico and in vitro functional assays, including chorioallantoic membrane (CAM) assays.
• Investigation of the role of TGF-β signaling in mediating Wnt-driven effects.

Main Results:

• β-catenin activation in Ewing sarcoma cells upregulates angiogenic switch genes and promotes angiogenesis.
• These cells secrete a proangiogenic ECM, termed the angiomatrix.
• Wnt/β-catenin signaling indirectly induces the angiomatrix via TGF-β, by antagonizing EWS-FLI1 repression of TGF-β receptor type 2.

Conclusions:

• Wnt/β-catenin-active Ewing sarcoma cells promote angiogenesis within the TME.
• This process involves the indirect induction of the angiomatrix mediated by TGF-β.
• Targeting Wnt/β-catenin signaling or its downstream effects may offer therapeutic strategies for Ewing sarcoma.